The statistical software revolution in pharmaceutical development: challenges and opportunities in open source

  • Daniel Sabanés Bové*
  • , Heidi Seibold
  • , Anne-Laure Boulesteix
  • , Juliane Manitz
  • , Alessandro Gasparini
  • , Burak K. Günhan
  • , Oliver Boix
  • , Armin Schüler
  • , Sven Fillinger
  • , Sven Nahnsen
  • , Anna E. Jacob
  • , Thomas Jaki
  • *Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Open-source statistical software development is increasingly the preferred solution for leveraging new statistical methods in the pharmaceutical industry. However, with a long history of relying on licensed analysis software, there are philosophical and organizational barriers to overcome. In particular, the sustainability, reliability, usability, and feasibility of maintaining open-source statistical software long-term must be ensured. Here, we describe the open-source revolution that is emerging in the pharmaceutical industry and how it facilitates greater scaling of innovative analytical methods in statistics. We discuss challenges to open-source software adoption and propose mitigation strategies. Furthermore, we illustrate the potential for open-source software development with examples of successful projects, which highlight the roles of cross-company collaboration, career paths, education, and community building.
Original languageEnglish
Article number104613
JournalDrug Discovery Today
ISSN1359-6446
DOIs
Publication statusAccepted/In press - 2026

Keywords

  • Software
  • Open source
  • Statistics
  • Clinical trials
  • Pharmaceutical industry
  • Academia

Fingerprint

Dive into the research topics of 'The statistical software revolution in pharmaceutical development: challenges and opportunities in open source'. Together they form a unique fingerprint.

Cite this